Scilex Holding Company (SCLX) Announces Entry into Material Definitive Agreement with Datavault AI Inc.

PALO ALTO, CA – April 28, 2026 – Scilex Holding Company (NASDAQ: SCLX), a leading developer of non-opioid pain management products, has filed a Form 8-K disclosing the entry into a material definitive agreement with Datavault AI Inc. This new development may have significant implications for the company’s future business strategy and could potentially impact the company’s share price.

Key Points from the Report

• Material Definitive Agreement Signed: On April 26, 2026, Scilex Holding Company signed a Term Sheet with Datavault AI Inc., marking the beginning of a new partnership between the two companies.
• Nature and Purpose of the Agreement: While the specific details of the agreement are not disclosed in the current filing, the company has emphasized that the Term Sheet represents a binding commitment to pursue a broader transaction or collaboration with Datavault AI Inc.
• Future Disclosure: Scilex Holding Company has stated that it will file the full text of the Term Sheet as an exhibit to its Quarterly Report on Form 10-Q for the quarter ending June 30, 2026.
• Potential Risks: The filing notes that there is a risk of disputes or litigation regarding the interpretation, enforceability, and/or performance of the Term Sheet. Such disputes could be costly, time-consuming, and divert management attention, potentially affecting the company’s financial condition and liquidity.
• Uncertainty on Transaction Completion: Investors are cautioned not to place undue reliance on the consummation of the proposed transaction, as there is no guarantee that either party will achieve related milestones or financial thresholds.

Important Considerations for Shareholders

• Potential Share Price Impact: The announcement of a material definitive agreement, especially with a technology company like Datavault AI Inc., could be seen as a strategic move to diversify or enhance Scilex’s capabilities. This could be viewed positively by the market, especially if the collaboration brings innovative technologies or revenue opportunities.
• Emerging Growth Company Status: Scilex Holding Company continues to qualify as an emerging growth company and has elected not to use the extended transition period for complying with new or revised financial accounting standards. This status may offer certain regulatory and reporting advantages.
• Securities Registered: The company’s common stock (SCLX) and warrants (SCLXW, each with an exercise price of \$402.50) are listed on The Nasdaq Stock Market LLC.
• Shareholder Caution: The company has explicitly warned shareholders about the uncertainty of the transaction’s completion and the risk of potential litigation, which could negatively affect the company’s liquidity and financial position.

Summary Table: Securities Information

Investor Takeaway

This newly disclosed agreement with Datavault AI Inc. is a noteworthy development for Scilex Holding Company. While the specific details and potential financial impact are yet to be revealed, the announcement signals the company’s intent to explore new technological or business opportunities. Investors should monitor future filings closely, particularly the upcoming Form 10-Q, which will contain the full agreement details. The outcome and success of this transaction could influence Scilex’s strategic direction and share value, but shareholders should be mindful of the risks and uncertainties highlighted by management.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should perform their own due diligence and consult with a professional advisor before making investment decisions. The information is based on a Form 8-K filing by Scilex Holding Company dated April 28, 2026, and may be subject to change as new details emerge.

View Scilex Holding Co Historical chart here